IBI-363

• Description :

  IBI-363 is a PD-1/IL-2 bispecific antibody and can be used for the research of cancer, such as non-small cell lung cancer[1].

• UNSPSC :

  12352005

• Target :

  Interleukin Related; PD-1/PD-L1

• Related Pathways :

  Immunology/Inflammation

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Smiles :

  [IBI-363]

• References & Citations :

  [1]Zhou J, et al. MA11. 04 first-in-class PD-1/IL-2 bispecific antibody IBI363 in patients with advanced non-small cell lung cancer in a phase I study[J]. Journal of Thoracic Oncology, 2024, 19 (10) : S97.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  No Development Reported

• Isoform :

  IL-2